Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 37

Sort by

Sort Order Select

Journal Articles

Administration of Andexanet Alfa for Direct Factor Xa Inhibitor Reversal Precludes Therapeutic Heparinization for Cardiopulmonary Bypass

Nabil K. Thalji, MD PhD, Prakash A Patel, MD, Rodney M. Camire, PhD

Blood (2019) 134 (Supplement_1): 3640.

https://doi.org/10.1182/blood-2019-125955

Published: 2019

Journal Articles

Delayed Time to Emergency Hip Surgery in Patients Taking Oral Anticoagulants

Teresa Cafaro, MD, Vicky Tagalakis, MD FRCPC, Maral Koolian, MD FRCPC, Simard Camille, MD

Blood (2019) 134 (Supplement_1): 2445.

https://doi.org/10.1182/blood-2019-128849

Published: 2019

Journal Articles

Preoperative Transfusion in Pediatric Patient with Sickle Cell Disease

Mohamed Al Darwish, Sukainah Alabkary, Hajer Al deabel, Fatimah Alqatari, Wafa AlDubaisy

Blood (2019) 134 (Supplement_1): 4851.

https://doi.org/10.1182/blood-2019-127104

Published: 2019

Journal Articles

The Peri-Operative Management of Anticoagulants: Systemic Review of Guidelines

Salma Shivji, MDFRCPC, Philip Chiang, MBSc, Lana A Castellucci, MD FRCPC, MSc, Elianna Saidenberg, MD FRCPC

Blood (2019) 134 (Supplement_1): 4974.

https://doi.org/10.1182/blood-2019-128395

Published: 2019

Journal Articles

Study on the Possibility of Emergency Percutaneous Coronary Intervention (PCI) in Myeloproliferative Neoplasms (MPNs) Patients with Acute Coronary Syndrome (ACS)

Ye Chen, Xiuchuan Qin, Xue Han, Beibei Bai, Yingchun Wang

Blood (2019) 134 (Supplement_1): 5375.

https://doi.org/10.1182/blood-2019-124612

Published: 2019

Journal Articles

The Appropriateness of Fresh Frozen Plasma (FFP) Administration in the Community Teaching Hospital

Sufana Shikdar, MD MPH, Nicholas Ghionni, DO, Eric Green, MD MSc, Kakageldi Hommadov, MD

Blood (2018) 132 (Supplement 1): 5823.

https://doi.org/10.1182/blood-2018-99-110246

Published: 2018

Journal Articles

Monitoring the Effects of Direct Oral Anticoagulants with a Novel Point-of-Care Sensor: Results of a Pilot Clinical Study

Aman Opneja, MBBS, Debnath Maji, M.Tech, Pedram Mohseni, PhD, Michael A Suster, PhD, Evi X Stavrou, MD

Blood (2018) 132 (Supplement 1): 988.

https://doi.org/10.1182/blood-2018-99-118943

Published: 2018

Journal Articles

Surgical Experience in Two Multicenter, Open-Label Phase 3 Studies of Emicizumab in Persons with Hemophilia A with Inhibitors (HAVEN 1 and HAVEN 2)

Rebecca Kruse-Jarres, Michael U. Callaghan, Stacy E. Croteau, MD, Victor Jimenez-Yuste, Liane Khoo, Ri Liesner, Tadashi Matsushita, Michael Recht, Guy Young, Tiffany Chang, Christophe Dhalluin, Yunming Mu, Jin Xu, Jenny Devenport, Richard H. Ko, Paul Solari, Johannes Oldenburg

Blood (2017) 130 (Supplement 1): 89.

https://doi.org/10.1182/blood.V130.Suppl_1.89.89

Published: 2017

Journal Articles

Single Centre Retrospective Analysis of Patients Who Underwent Emergency Reversal of Warfarin Anticoagulation

Muhajir Bawa Mohamed, MDDM,FRACP,FRCPA,, Gerald Bates, Robert Hayes, Michael Morse, Ajay Prakash, Waheedha Basheer

Blood (2017) 130 (Supplement 1): 4913.

https://doi.org/10.1182/blood.V130.Suppl_1.4913.4913

Published: 2017

Journal Articles

The Use of 4F-PCC to Correct Direct Oral Anticoagulant (DOAC)-Induced Coagulopathy: An Observational Analysis

Yan Zheng, MD PhD, Christopher Tormey, MD

Blood (2017) 130 (Supplement 1): 4912.

https://doi.org/10.1182/blood.V130.Suppl_1.4912.4912

Published: 2017

Journal Articles

Descriptive Analysis of Idarucizumab (Praxbind ® ) Use in a National Hospital Database

John House, MS, Jessica Franchino-Elder, PhD, Roberta James, MStat, Harold Brown, MBA, Cheng Weng, MD PhD, Mohd Azhar Bin Ahmad, MD MBBC, MRCP

Blood (2017) 130 (Supplement 1): 3714.

https://doi.org/10.1182/blood.V130.Suppl_1.3714.3714

Published: 2017

Journal Articles

Successful Treatment of Bleeding in Acquired Hemophilia A with Activated Prothrombin Complex Concentrate in Spain

Maria Eva Mingot-Castellano, PhD MD, Rocio Pérez-Montes, MD, Mariana Canaro, PhD MD, Ana Marco, PhD MD, Victoria Calle-Gordo, MD, Ana Isabel Heiniger, MD

Blood (2017) 130 (Supplement 1): 3688.

https://doi.org/10.1182/blood.V130.Suppl_1.3688.3688

Published: 2017

Journal Articles

Implementation and Impact of a Multidisciplinary Coagulation Factor Stewardship Program

Justin Fongemie, PharmD, Srila Gopal, Kimberly S Esham, MD, Leslie Richardson-Weber, MT(ASCP), Lulu Zhang, MD MPH, Anem Waheed, MD, Layla Van Doren, MD, Rachel J. Buchsbaum, MD, Raymond L. Comenzo, MD

Blood (2017) 130 (Supplement 1): 2083.

https://doi.org/10.1182/blood.V130.Suppl_1.2083.2083

Published: 2017

Journal Articles

Rationale and Design of a Phase III Safety Trial of Idarucizumab in Children Receiving Dabigatran Etexilate for the Treatment and Secondary Prevention of Venous Thromboembolism

Manuela Albisetti, MD, Arno Schlosser, MSc, Martina Brueckmann, MD, Savion Gropper, MD, Stephan Glund, PhD, Igor Tartakovsky, MD, Leonardo R. Brandão, MD MSc, Paul A Reilly, PhD

Blood (2016) 128 (22): 5010.

https://doi.org/10.1182/blood.V128.22.5010.5010

Published: 2016

Journal Articles

Rotational Thromboelastometry (ROTEM) for Assessing the Anticoagulant Effect of Rivaroxaban: A Single-Centre Cohort Study

Thomas Andrew Fox, MRCP, Andrew Wood, Anne Riddell, Pratima Chowdary, Anja B Drebes

Blood (2016) 128 (22): 5018.

https://doi.org/10.1182/blood.V128.22.5018.5018

Published: 2016

Journal Articles

Idarucizumab, a Specific Reversal Agent for Dabigatran: Immediate, Complete and Sustained Reversal of Dabigatran-Induced Anticoagulation in Japanese Healthy Male Volunteers

Joanne van Ryn, PhD, Masahiro Yasaka, MD PhD, Ippei Ikushima, MD PhD, Akiko Harada, PhD, Atsushi Taniguchi, MSc, Susumu Imazu, PhD, Stephen Norris, PhD, Dietmar Gansser, PhD, Joachim Stangier, PhD

Blood (2016) 128 (22): 2627.

https://doi.org/10.1182/blood.V128.22.2627.2627

Published: 2016

Journal Articles

Clinical Course and Management of Surgical Emergency in a Severe Hemophilia a Patient Under Weekly Subcutaneous Administration of a Bispecific Antibody to Factors IXa and X (ACE910)

Takeshi Kanematsu, MD, Nobuaki Suzuki, MD PhD, Naomi Sanda, MSc, Mika Ogawa, MD, Mayuko Kishimoto, MD PhD, Atsuo Suzuki, PhD, Hitoshi Kiyoi, MD PhD, Ryu Kasai, MSc, Tadashi Matsushita, MD PhD

Blood (2015) 126 (23): 1099.

https://doi.org/10.1182/blood.V126.23.1099.1099

Published: 2015

Journal Articles

Perioperative Efficacy of an Extended Half-Life, Pegylated, Full-Length, Recombinant Factor VIII (BAX 855) in Individual Procedures

Brigitte Brand, Ralph A. Gruppo, MD, Tung T. Wynn, Laimonas Griskevicius, Maria Fernanda Lopez Fernandez, Thomas Dvorak, Lisa Patrone, Brigitt E. Abbuehl

Blood (2015) 126 (23): 2299.

https://doi.org/10.1182/blood.V126.23.2299.2299

Published: 2015

Journal Articles

Efficacy and Safety of Four Factor Prothrombin Complex Concentrates As a Reversal Agent for Oral Xa Inhibitors

Krishna Gundabolu, MD, Brian Trevarrow, BA, Pharm.D., BCPS, Scott A Koepsell, MD, PhD, FCAP

Blood (2015) 126 (23): 4668.

https://doi.org/10.1182/blood.V126.23.4668.4668

Published: 2015

Journal Articles

FEIBA™ for Patients on Direct Oral Anticoagulants Requiring Urgent Surgery

Joseph Shaw, B.Sc, Gregoire Le Gal, MDPhD, Melanie Tokessy, Nancy Cober, Elianna Saidenberg, MD, Marc Carrier, MDMSc, Lana Castellucci, MDMSc

Blood (2014) 124 (21): 4259.

https://doi.org/10.1182/blood.V124.21.4259.4259

Published: 2014

NARROW

Administration of Andexanet Alfa for Direct Factor Xa Inhibitor Reversal Precludes Therapeutic Heparinization for Cardiopulmonary Bypass

Delayed Time to Emergency Hip Surgery in Patients Taking Oral Anticoagulants

Preoperative Transfusion in Pediatric Patient with Sickle Cell Disease

The Peri-Operative Management of Anticoagulants: Systemic Review of Guidelines

Study on the Possibility of Emergency Percutaneous Coronary Intervention (PCI) in Myeloproliferative Neoplasms (MPNs) Patients with Acute Coronary Syndrome (ACS)

The Appropriateness of Fresh Frozen Plasma (FFP) Administration in the Community Teaching Hospital

Monitoring the Effects of Direct Oral Anticoagulants with a Novel Point-of-Care Sensor: Results of a Pilot Clinical Study

Surgical Experience in Two Multicenter, Open-Label Phase 3 Studies of Emicizumab in Persons with Hemophilia A with Inhibitors (HAVEN 1 and HAVEN 2)

Single Centre Retrospective Analysis of Patients Who Underwent Emergency Reversal of Warfarin Anticoagulation

The Use of 4F-PCC to Correct Direct Oral Anticoagulant (DOAC)-Induced Coagulopathy: An Observational Analysis

Descriptive Analysis of Idarucizumab (Praxbind ® ) Use in a National Hospital Database

Successful Treatment of Bleeding in Acquired Hemophilia A with Activated Prothrombin Complex Concentrate in Spain

Implementation and Impact of a Multidisciplinary Coagulation Factor Stewardship Program

Rationale and Design of a Phase III Safety Trial of Idarucizumab in Children Receiving Dabigatran Etexilate for the Treatment and Secondary Prevention of Venous Thromboembolism

Rotational Thromboelastometry (ROTEM) for Assessing the Anticoagulant Effect of Rivaroxaban: A Single-Centre Cohort Study

Idarucizumab, a Specific Reversal Agent for Dabigatran: Immediate, Complete and Sustained Reversal of Dabigatran-Induced Anticoagulation in Japanese Healthy Male Volunteers

Clinical Course and Management of Surgical Emergency in a Severe Hemophilia a Patient Under Weekly Subcutaneous Administration of a Bispecific Antibody to Factors IXa and X (ACE910)

Perioperative Efficacy of an Extended Half-Life, Pegylated, Full-Length, Recombinant Factor VIII (BAX 855) in Individual Procedures

Efficacy and Safety of Four Factor Prothrombin Complex Concentrates As a Reversal Agent for Oral Xa Inhibitors

FEIBA™ for Patients on Direct Oral Anticoagulants Requiring Urgent Surgery

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only